Cibus (CBUS) Net Cash Flow (2016 - 2025)
Cibus (CBUS) posted Net Cash Flow of -$13.9 million for Q4 2025, down 10.65% sequentially from -$12.6 million in Q3 2025, and up 2.88% YoY from -$13.6 million in Q4 2024.
Cibus (CBUS) Net Cash Flow (2016 - 2025) Analysis & Trends
Cibus has reported Net Cash Flow for 10 years, with the latest figure at -$13.9 million in Q4 2025.
- Quarterly Net Cash Flow rose 2.88% year-over-year to -$13.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.5 million (up 75.18% YoY) and the FY2025 annual result came in at -$4.5 million, up 75.18% from the prior year.
- Net Cash Flow fell to -$13.9 million in Q4 2025 per CBUS's latest filing, from -$12.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $48.8 million in Q2 2023 and troughed at -$19.0 million in Q3 2023.
- A 5-year average of -$418800.0 and a median of -$1.3 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow surged 918.16% in 2023, then tumbled 1870.28% in 2024.
- Over 5 years, Net Cash Flow stood at -$492000.0 in 2021, then plunged by 647.76% to -$3.7 million in 2022, then jumped by 122.04% to $811000.0 in 2023, then sank by 1870.28% to -$14.4 million in 2024, then increased by 2.88% to -$13.9 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$13.9 million, -$12.6 million, and $12.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.94 Mn |
| Dec 31, 2025 | -13.94 Mn |
| Sep 30, 2025 | -12.60 Mn |
| Sep 30, 2025 | -12.60 Mn |
| Jun 30, 2025 | 12.84 Mn |
| Jun 30, 2025 | 12.84 Mn |
| Mar 31, 2025 | 9.18 Mn |
| Mar 31, 2025 | 9.18 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | -8.19 Mn |
| Mar 31, 2024 | -8.19 Mn |
| Dec 31, 2023 | 811,000.00 |
| Dec 31, 2023 | 811,000.00 |
| Sep 30, 2023 | -19.01 Mn |
| Sep 30, 2023 | -19.01 Mn |